Oculis Holding AG (FRA:CR5) Long-Term Debt : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Long-Term Debt?

Oculis Holding AG's Long-Term Debt for the quarter that ended in Mar. 2024 was €0.00 Mil.

Oculis Holding AG's annual Long-Term Debt increased from Dec. 2021 (€109.07 Mil) to Dec. 2022 (€124.08 Mil) but then declined from Dec. 2022 (€124.08 Mil) to Dec. 2023 (€0.00 Mil).

Oculis Holding AG Long-Term Debt Historical Data

The historical data trend for Oculis Holding AG's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oculis Holding AG Long-Term Debt Chart

Oculis Holding AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

49.94

109.07

124.08

Oculis Holding AG Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial							-	-	-	-	-

Oculis Holding AG (FRA:CR5) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Oculis Holding AG Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Oculis Holding AG's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Oculis Holding AG (FRA:CR5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (FRA:CR5) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

OCS:USA OCS:Iceland

Address

Bahnhofstrasse 7, Zug, CHE, 6300

Website

https://www.oculis.com

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Oculis Holding AG (FRA:CR5) Headlines

No Headlines